Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta

Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta


Biogen Inc and AbbVie Inc have withdrawn their multiple sclerosis drug worldwide due to safety issues, the companies said on Friday. FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017.



from Biotech News